[待更新] Herceptin (trastuzumab) is part of a treatment plan for the adjuvant treatment of patients with HER2 overexpressing, node-positive HER2+ breast cancer. Who is Herceptin for? Herceptin is approved for the adjuvant treatment of HER2-overexpressing, nod...oman. Please see the full Prescribing Information for Serious Side Effects and additional important...
